Early-onset GI cancers diagnosed before age 50 are rising at alarming rates worldwide, underscoring the need for enhanced ...

British consumer healthcare group Haleon lowered its annual revenue growth forecast to about 3.5% on Thursday after ...

British pharmaceutical group GlaxoSmithKline said Wednesday that its annual performance should be better than expected, ...

"Longer follow-ups after the pandemic are needed to investigate persistent brain aging effects and their long-term ...

UK-based big pharma GlaxoSmithKline (GSK) has released its Q2 2025 results, which highlight the varying successes of its ...

GlaxoSmithKline ( ($GSK) ) has released its Q2 earnings. Here is a breakdown of the information GlaxoSmithKline presented to its investors.

Shares of GSK fell to below $30 around the time of the demerger, but have since recovered to about $36. The 20% gain over 34 ...

The deal would give GSK the rights to develop the drug for HRS-9821 and 11 preclinical programmes owned by Jiangsu Hengrui ...

GSK will partner with Hengrui Pharma to develop up to 12 treatments for indications in respiratory, immunology and ...

The global chicken pox market is experiencing significant growth driven by the widespread prevalence of the varicella-zoster virus, low vaccination r ...

If successful, M72 might be the first new TB vaccine in more than a century to meet the WHO's target product profile, ...